{"organizations": [], "uuid": "d633493c918f1dc221bca6fd3a557be741d8c0b2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180409.html", "section_title": "Archive News &amp; Video for Monday, 09 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/polyphor-ipo/swiss-speciality-drugs-company-polyphor-announces-plans-to-float-idUSZ8N1QN01M", "country": "US", "domain_rank": 408, "title": "Swiss speciality drugs company Polyphor announces plans to float", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.572, "site_type": "news", "published": "2018-04-09T13:19:00.000+03:00", "replies_count": 0, "uuid": "d633493c918f1dc221bca6fd3a557be741d8c0b2"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/polyphor-ipo/swiss-speciality-drugs-company-polyphor-announces-plans-to-float-idUSZ8N1QN01M", "ord_in_thread": 0, "title": "Swiss speciality drugs company Polyphor announces plans to float", "locations": [], "entities": {"persons": [{"name": "murepavadin", "sentiment": "none"}, {"name": "john revill", "sentiment": "none"}, {"name": "john miller", "sentiment": "none"}], "locations": [{"name": "zurich", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "polyphor", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "ZURICH, April 9 (Reuters) - Swiss speciality pharmaceuticals company Polyphor on Monday said it plans to raise 100 million to 150 million Swiss francs ($104.21 million to $156.32 million) by floating on the Swiss stock exchange.\nThe company said it would use the funds to develop Murepavadin, a drug to treat a strain of pneumonia with high levels of mortality. ($1 = 0.9596 Swiss francs) (Reporting by John Revill, editing by John Miller)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-09T13:19:00.000+03:00", "crawled": "2018-04-10T12:37:18.000+03:00", "highlightTitle": ""}